EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC 4.0

TP53 Mutation Status in Myelodysplastic Neoplasm and Acute Myeloid Leukemia: Impact of Reclassification Based on the 5th WHO and International Consensus Classification Criteria: A Korean Multicenter Study

Hyun-Young Kim iD, Saeam Shin iD, Jong-Mi Lee iD, In-Suk Kim iD, Boram Kim iD, Hee-Jin Kim iD, Yu Jeong Choi iD, Byunggyu Bae iD, Yonggoo Kim iD, Eunhui Ji iD, Hyerin Kim iD, Hyerim Kim iD und 9 weitere

Annals of Laboratory Medicine · 2025

DOI: 10.3343/alm.2024.0351 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Annals of Laboratory Medicine, 2025. Verfasst von Hyun-Young Kim und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Tumor Suppressor Protein p53, Mutation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myelodysplastic SyndromesLeukemia, Myeloid, AcuteTumor Suppressor Protein p53MutationHumansMaleFemaleMiddle AgedAgedRepublic of KoreaAdultAged, 80 and overYoung AdultHigh-Throughput Nucleotide SequencingWorld Health OrganizationGene FrequencyAdolescent

Stichwörter der Autor:innen

Acute myeloid leukemiaInternational Consensus ClassificationMyelodysplastic syndromesTP53 mutationWorld Health Organization

Substanzen

Tumor Suppressor Protein p53TP53 protein, human

Autor:innen und Institutionen

  • Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Korea.
  • Department of Laboratory Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Department of Laboratory Medicine, Pusan National University School of Medicine, Pusan National University Yangsan Hospital, Yangsan, Korea.
  • Department of Laboratory Medicine, Pusan National University School of Medicine, Pusan National University Hospital, Busan, Korea.
  • Department of Laboratory Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.

ORCID-Profile: Hyun-Young Kim, Saeam Shin, Jong-Mi Lee, In-Suk Kim, Boram Kim, Hee-Jin Kim, Yu Jeong Choi, Byunggyu Bae, Yonggoo Kim, Eunhui Ji, Hyerin Kim, Hyerim Kim, Jee-Soo Lee, Yoon Hwan Chang, Hyun Kyung Kim, Ja Young Lee, Shinae Yu, Miyoung Kim, Young-Uk Cho, Seongsoo Jang, Myungshin Kim

Zitieren

APA

Kim, H. Y., Shin, S., Lee, J. M., Kim, I. S., Kim, B., Kim, H. J., Choi, Y. J., Bae, B., Kim, Y., Ji, E., Kim, H., Kim, H., Lee, J. S., Chang, Y. H., Kim, H. K., Lee, J. Y., Yu, S., Kim, M., Cho, Y. U., …, & Kim, M. (2025). TP53 Mutation Status in Myelodysplastic Neoplasm and Acute Myeloid Leukemia: Impact of Reclassification Based on the 5th WHO and International Consensus Classification Criteria: A Korean Multicenter Study. Annals of Laboratory Medicine. https://doi.org/10.3343/alm.2024.0351

Vancouver

Kim HY, Shin S, Lee JM, Kim IS, Kim B, Kim HJ, et al. TP53 Mutation Status in Myelodysplastic Neoplasm and Acute Myeloid Leukemia: Impact of Reclassification Based on the 5th WHO and International Consensus Classification Criteria: A Korean Multicenter Study. Annals of Laboratory Medicine. 2025. doi:10.3343/alm.2024.0351

BibTeX
@article{Kim2025,
  author = {Kim, Hyun-Young and Shin, Saeam and Lee, Jong-Mi and Kim, In-Suk and Kim, Boram and Kim, Hee-Jin and Choi, Yu Jeong and Bae, Byunggyu and Kim, Yonggoo and Ji, Eunhui and Kim, Hyerin and Kim, Hyerim and Lee, Jee-Soo and Chang, Yoon Hwan and Kim, Hyun Kyung and Lee, Ja Young and Yu, Shinae and Kim, Miyoung and Cho, Young-Uk and Jang, Seongsoo and Kim, Myungshin},
  title = {TP53 Mutation Status in Myelodysplastic Neoplasm and Acute Myeloid Leukemia: Impact of Reclassification Based on the 5th WHO and International Consensus Classification Criteria: A Korean Multicenter Study},
  journal = {Annals of Laboratory Medicine},
  year = {2025},
  doi = {10.3343/alm.2024.0351}
}
Kostenlos starten →